Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

OTHER 1

Study Type

Interventional 1Expanded_access 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1CNS 1

Conditions

Insulinoma 2Thyroid cancer, medullary 1Pheochromocytoma 1Paraganglioma 1Neuroblastoma 1Hypoglycemia 1Hyperinsulinism 1Congenital Hyperinsulinism 1Carcinoid Tumor 1Beckwith-Wiedemann Syndrome 1

Interventions

3-Iodobenzylguanidine 6pegfilgrastim 1fluorodopa F 18 1Vorinostat 1Potassium Iodide 1Granulocyte Colony-Stimulating Factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × Pheochromocytoma × fluorodopa F 18 × Clear all
NCT02431715 2023-02-21

18F-FDOPA PET in Neuroendocrine Tumours

British Columbia Cancer Agency

No longer available
CNSEndocrineHead & Neck

Thyroid cancer, medullary, Carcinoid Tumor, Insulinoma, Neuroblastoma, Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡